Improving patient recruitment to randomised trials can be cost-effective: A case-study of dexamethasone from the RECOVERY trial - Athanasios Gkekas; Sarah J. Ronaldson; Adwoa Parker; David J. Torgerson (PLoS ONE, 2025)